NCCN Guideline: Distress Management

10 Oct, 2019 | 09:06h | UTC

Cardiac Amyloidosis: Updates in Imaging

27 Aug, 2019 | 00:21h | UTC

Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant – JAMA Internal Medicine (free for a limited period)

Commentary: Study Sheds Light on Stopping and Resuming DOACs in Afib Patients Undergoing Surgery – NEJM Journal Watch (free)

“The DOAC regimens were omitted for 1 day before a low–bleeding-risk procedure and 2 days before a high–bleeding-risk procedure. The DOAC regimens were resumed 1 day after a low–bleeding-risk procedure and 2 to 3 days after a high–bleeding-risk procedure.”


Related Commentary on Twitter


Clinical Guide and Update on Porphyrias

26 Jul, 2019 | 01:11h | UTC

Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis – The BMJ (free)

Commentary: Long-Term Risk for Recurrent VTE Significant After Stopping Anticoagulation – NEJM Journal Watch (free)

“the risk of recurrent VTE was 10% in the first year after treatment, 16% at two years, 25% at five years, and 36% at 10 years, with 4% of recurrent VTE events resulting in death.”


Related Commentary on Twitter


The Promise and Price of Cellular Therapies – The New Yorker (a few articles per month are free)

“New “living drugs”—made from a patient’s own cells—can cure once incurable cancers. But can we afford them?”


NCCN Guideline: Acute Myeloid Leukemia

2 Jul, 2019 | 01:16h | UTC

Vitamin K for reversal of excessive vitamin K antagonist anticoagulation: a systematic review and meta-analysis – Blood Advances (free)

Our findings indicate that patients on VKA therapy who have an INR between 4.5 and 10.0 without bleeding are not likely to benefit from vitamin K administration in addition to temporary VKA cessation.”


NCCN Guideline: Systemic Mastocytosis

9 Jan, 2019 | 08:48h | UTC

Transfusion of red blood cells stored for shorter versus longer duration for all conditions – Cochrane Library (free)

Summary: Transfusion of red blood cells stored for a shorter duration versus red blood cells stored for a longer duration for all conditions – Cochrane Library (free)



Review: Cancer-Associated Thrombosis

5 Nov, 2018 | 11:51h | UTC

NICE Guideline: Multiple Myeloma

2 Nov, 2018 | 02:33h | UTC

Intravenous Iron in Patients Undergoing Maintenance Hemodialysis – New England Journal of Medicine (free)

“Proactive administration of high-dose iv iron did not adversely affect mortality or CV events, but enabled reduced erythropoiesis-stimulating agent dosing and transfusion rates.” (via @NatRevNeph see Tweet)


Review: Cancer-Associated Thrombosis

16 Oct, 2018 | 21:45h | UTC

Review: Rare Thrombophilic Conditions

16 Oct, 2018 | 21:34h | UTC

Guideline: Immune Thrombocytopenia

27 Sep, 2018 | 22:25h | UTC

Guideline: Hodgkin Lymphoma in Adults

2 Sep, 2018 | 02:03h | UTC

Six-Month Outcomes after Restrictive or Liberal Transfusion for Cardiac Surgery – New England Journal of Medicine (free for a limited period)

“In moderate-to-high-risk patients undergoing cardiac surgery, six-month outcomes show that a restrictive red-cell transfusion strategy is noninferior to a liberal strategy” (via @NEJM see Tweet with Visual Abstract)


Guideline: Pediatric CAR T-Cell Therapy

16 Aug, 2018 | 23:16h | UTC

ESMO Guideline: Hodgkin lymphoma

1 Jun, 2018 | 03:12h | UTC

Global Burden of Multiple Myeloma: A Systematic Analysis for the Global Burden of Disease Study 2016 – JAMA Oncology (free)

“Global incident cases of multiple myeloma more than doubled from 1990-2016 w/incident cases increasing by 126%. The largest increase was in middle-SDI countries, particularly E. Asia with a 262% increase in incidence cases”. (via @IHME_UW see Tweet)


Review: Chronic Lymphocytic Leukemia

9 May, 2018 | 16:15h | UTC